APA (7th ed.) Citation

Elena Muensterman, Benjamin Engelhardt, Sathej Gopalakrishnan, Jaclyn K. Anderson, & Mohamed‐Eslam F. Mohamed. (2022). Upadacitinib pharmacokinetics and exposure‐response analyses of efficacy and safety in psoriatic arthritis patients - Analyses of phase III clinical trials. Wiley.

Chicago Style (17th ed.) Citation

Elena Muensterman, Benjamin Engelhardt, Sathej Gopalakrishnan, Jaclyn K. Anderson, and Mohamed‐Eslam F. Mohamed. Upadacitinib Pharmacokinetics and Exposure‐response Analyses of Efficacy and Safety in Psoriatic Arthritis Patients - Analyses of Phase III Clinical Trials. Wiley, 2022.

MLA (9th ed.) Citation

Elena Muensterman, et al. Upadacitinib Pharmacokinetics and Exposure‐response Analyses of Efficacy and Safety in Psoriatic Arthritis Patients - Analyses of Phase III Clinical Trials. Wiley, 2022.